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Abstract
Background: Monocyte-derived macrophages and dendritic cells (DCs) are important in inflammatory processes
and are often used for immunotherapeutic approaches. Blood monocytes can be differentiated into macrophages
and DCs, which is accompanied with transcriptional changes in many genes, including chemokines and cell surface
markers.
Results: To study the chromatin modifications associated with this differentiation, we performed a genome wide
analysis of histone H3 trimethylation on lysine 4 (H3K4me3) and 27 (H3K27me3) as well as acetylation of H3 lysines
(AcH3) in promoter regions. We report that both H3K4me3 and AcH3 marks significantly correlate with
transcriptionally active genes whereas H3K27me3 mark is associated with inactive gene promoters. During
differentiation, the H3K4me3 levels decreased on monocyte-specific CD14, CCR2 and CX3CR1 but increased on DC-
specific TM7SF4/DC-STAMP, TREM2 and CD209/DC-SIGN genes. Genes associated with phagocytosis and antigen
presentation were marked by H3K4me3 modifications. We also report that H3K4me3 levels on clustered chemokine
and surface marker genes often correlate with transcriptional activity.
Conclusion: Our results provide a basis for further functional correlations between gene expression and histone
modifications in monocyte-derived macrophages and DCs.
Background
Human peripheral blood monocytes are derived from
myeloid progenitors in bone marrow. After their
maturation, they migrate to the periphery and form
approximately 5-10% of human leukocytes. Monocytes
circulate in the blood stream for several days and then
enter to peripheral tissues where they undergo a pheno-
typic change and differentiate further into macrophages
or dendritic cells (DCs) [1-4]. In tissues, macrophages
have a central role to locally phagocytose and destroy
pathogens, to clear senescent cells and to repair tissues
after the inflammatory processes [5]. Activated macro-
phages show strong inflammatory responses through the
high production of pro-inflammatory cytokines and
increased endocytic and antigen presentation activity.
Similarly to macrophages, DCs are located in peripheral
tissues where they encounter and phagocytose microbes.
The recognition of microbial antigen occurs in the
immature state of DCs and leads to a maturation pro-
cess, after which they have increased antigen presenta-
tion but downregulated antigen recognition capacity.
The maturation is often accompanied with the migra-
tion of DCs to secondary lymphoid organs [6] and sev-
eral murine DC subsets with variable phenotype,
function or tissue locations have been reported [7].
The peripheral blood monocytes exhibit a heteroge-
neous phenotype with respect to their size and nuclear
morphology. They can be relatively easily identified by
high expression of the cell surface marker CD14 and can
be divided into at least two major subpopulations accord-
ing to their CD16 expression [3]. DCs derived from
monocytes are particularly important during inflamma-
tory processes and are efficient in stimulating CD4 and
CD8 positive T cell responses [8-11]. Recent studies
showed that monocytes can also differentiate into macro-
phages and DCs under non-inflammatory conditions and
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antigen capture areas, such as skin, mucosa, gastrointest-
inal and respiratory track, are in fact derived from mono-
cytes [12,13]. To generate a large number of human
macrophages or DCs, monocytes are typically cultured
for several days in the presence of granulocyte macro-
phage colony-stimulating factor (GM-CSF) alone or GM-
CSF with interleukin 4 (IL-4), respectively [14,15].
Although these culture conditions give rise to only one
subset of differentiated cells and do not represent the full
heterogeneity of macrophages or DCs in vivo, it still is
the most efficient way to obtain human antigen present-
ing cells. Furthermore, monocyte-derived DCs are by far
the most common type of cells used in immunotherapeu-
tic clinical approaches [16,17].
Histone modifications within promoter regions have
an important function in regulation of gene expression
[18]. The majority of modifications occur at the N-
terminal ends of the core histones in a nucleosome.
These modifications are often dynamic as well as rever-
sible and have a functional impact on many aspects of
chromatin accessibility that may determine the tran-
scriptional status of a given gene. One of the most fre-
quent histone modifications is the trimethylation of
histone H3 lysine 4 (H3K4me3), which in gene promo-
ters is usually associated with the transcriptional activa-
tion, whereas the trimethylation of histone H3 lysine 27
(H3K27me3) generally results in gene silencing. The
presence of these two opposing modifications as bivalent
marks on promoters is often associated with poised gene
transcription. Similar to the H3K4me3 mark, the acety-
lation of lysines on histone H3 (AcH3) is often asso-
ciated with transcriptional activation [18]. How exactly
these combinations of chromatin modifications translate
to gene transcription is currently under extensive inves-
tigation in several cell types. Transcriptional control is
further mediated by chromatin associated proteins; for
example H3K4me3 may serve as a docking site for PHD
finger domain and AcH3 for bromodomains [19].
Here we studied the histone H3K4me3, AcH3 and
H3K27me3 modifications in human monocytes, mono-
cyte-derived macrophages and DCs. To gain insight into
the role of these modifications during the differentiation
process, we compared genome-wide gene expression
profiles with histone changes in promoter regions over
the genome. We show that H3K4me3 and AcH3 marks
generally correlate well with gene expression and that
H3K27me3 is associated with inactive genes. We also
show that H3K4me3 levels are increased on the promo-
ters of several marker genes and gene groups during dif-
ferentiation. In addition, we provide evidence that the
chromatin statuses of gene families within genomic clus-
ters, including chemokine and surface receptor genes,
are coordinately modified.
Results
Genome-wide mRNA expression profiles
We first identified the expression profiles of monocytes,
macrophages and DCs using the Illumina Human-6 v2
BeadChip expression array. Overall, the gene expression
profiles in these three cell subsets were similar with a
high correlation coefficient (Additional file 1, Figure S1).
However, we found a significantly higher correlation
between the expression profiles of macrophage and DCs
than between monocytes and macrophages or mono-
cytes and DCs. When we used a selection criteria of a
2-fold change and differential P value less than 0.05, we
found that compared to monocytes, a similar number of
genes were upregulated in macrophages and DCs (1663
and 1630 genes, respectively). This represents 8% of the
total number (ca 21 000) of human genes (Table 1).
Approximately the same proportion of all genes were
also downregulated during macrophage (1952; 9%) or
DC (1654; 8%) differentiation. The majority of upregu-
lated (1037) or downregulated (1328) genes in macro-
phage and DC cultures overlapped, indicating again a
similarity between the two cell populations.
According to the expression array, the monocyte popu-
lation had a very high expression of CD14, CCR2,
CSF1R and SELL/CD62L mRNA, which were all down-
regulated after the differentiation to macrophages or
DCs (Table 2). In contrast, marker genes specific for
human CD16+ monocyte subpopulation, FCGR3A/
CD16A and FCGR3B/CD16B, were expressed at low
levels. In both macrophage and DC populations, we
observed a highly increased expression of surface marker
TM7SF4/DC-STAMP, TREM2 and chemokine CCL3
and CCL22 transcripts. In DCs, several additional sur-
face markers such as CD209/DC-SIGN, SLAM and CD1
family genes, were strongly upregulated, as well as the
chemokines CCL2, CCL13, CCL17, CCL23 and CCL26.
Altogether, the expression array data showed that
macrophages and DCs share similar global mRNA
expression pattern that is different from their monocyte
precursors.
Genome-wide chromatin profiling of promoter regions
To investigate the correlation between gene expression
profiles and histone modifications in monocytes, macro-
p h a g e sa n dD C s ,w eu s e dah i g h - r e s o l u t i o np r o m o t e r
microarray screen with immunoprecipitated chromatin
Table 1 Upregulated and downregulated genes in
macrophages and DCs
Cell Upregulated Downregulated
MF only 626 624
DC only 593 326
MF and DC 1037 1328
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immunoprecipitated with antibodies to H3K4me3,
H3K27me3 and AcH3, as well as to general H3. The
immunoprecipitated material was then hybridized to the
NimbleGen promoter array covering 19222 gene promo-
ters in the human genome that overlap with 17289
genes on the Illumina Human-6 v2 BeadChip expression
array. The ChIP-chip data with each modification-speci-
fic antibody was further normalized to random genomic
background and to general H3.
We first studied the occupancy and position of
H3K4me3, AcH3 and H3K27me3 marks in relation to
transcription start sites within the promoter regions.
H3K4me3 and AcH3 signals coincided up to 1000 bp
upstream and 500 bp downstream showing almost com-
plete overlap on both sides of the transcriptional start
s i t e s( F i g u r e1 ) .T h i sp a ttern was different from
H3K27me3, which was distributed more equally over
the promoter areas. The transcriptional start site itself
had remarkably lower H3K4me3 and AcH3 levels,
however, H3K27me3 signals that associate with silenced
genes (see below) were not significantly decreased at the
transcription start sites.
H3K4me3 and AcH3 have a high correlation on gene
promoters
We next analyzed the correlation between three marks
in three cell populations. As shown in Figure 2, there
was a highly significant correlation between H3K4me3
and AcH3 in three cell populations, while the
H3K27me3 mark was present on a distinct pool of gene
promoters. The most prevalent mark was the H3K4me3
present on 45% of all genes in monocytes, slightly less
in macrophages (43%) and even less in DCs (37%)
(Additional file 1, Figure S2). The AcH3 mark was
found in three cell subsets with nearly equal frequency,
being present on 30-32% of gene promoters. Of these
three modifications, the H3K27me3 mark had the lowest
frequency, and we found it more often in monocytes
(26%) or DCs (27%) than in macrophages (23%). Nota-
bly, a substantial proportion, more than one third (36 to
Table 2 Selected marker and cytokine gene expression
signals and their differential scores after differentiation
to macrophages and DCs
Gene MO MF DC
Signal Signal Score* Signal Score
CD1A 226 160 -4 7934 48
CD1B 34 794 9 11970 103
CD1C 308 105 -16 4012 39
CD4 1191 494 -26 452 -30
CD14 13904 4056 -41 122 -77
CD40 57 624 28 762 85
CCL2 19 1542 6 1022 54
CCL3 72 6355 49 3436 99
CCL13 7 462 6 21325 103
CCL17 1 65 21 19817 75
CCL22 15 7026 124 14991 103
CCL23 1 406 16 2200 18
CCL26 14 13 0 2295 26
CCR2 912 1 -26 2 -26
CSF1R 11566 3911 -26 6423 -11
LY9/SLAMF3 13 113 42 635 52
SLAMF7 63 851 58 1226 76
SLAMF8 52 2745 68 2182 98
SLAMF9 11 469 108 217 55
SELL/CD62L 2807 10 -77 7 -77
DC-SIGN/CD209 46 798 28 8191 102
DC-STAMP/TM7SF4 1 8783 125 3809 103
TREM2 1 1810 123 2834 103
*Illumina BeadStudio differential expression score indicates statistical
difference between expression levels. The differential score >13 corresponds
to statistically significant change with P-value less than 0.05. Positive values
correspond to upregulation and negative values to downregulation of
expression.
Figure 1 Location of H3K4me3, AcH3 and H3K27me3 peaks on
gene promoters in relation to transcription start sites. Average
density of the peaks across the all studied promoters in monocytes
(red), macrophages (green) and DCs (blue) is shown. The analyzed
promoter regions extended 2.0 kb upstream and 0.5 kb
downstream, 0 corresponds to transcription start site. The data are
normalized to H3 levels.
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Page 3 of 1339%) of gene promoters, lacked the histone modifica-
tions that were studied here. As expected, the most pre-
valent combination in all cells was the double
H3K4me3/AcH3 mark (25-28%) whereas the combina-
tion of H3K4me3 and H3K27me3 was present in only
5-6% of gene promoters (Additional file 1, Figure S3). A
notable proportion of genes (16-19%) was positive for
the H3K27me3 modification alone.
Transcriptionally active genes have a double modification
of H3K4me3 and AcH3
The H3K4me3 modification often overlaps with the
AcH3 mark on active genes, but in combination with
H3K27me3, it often marks genes poised for either acti-
vation or repression [20]. We therefore analyzed the
presence of histone marks among a subset of transcrip-
tionally active genes (Figure 3A). Similar to all genes in
the genome, the most common combination among
expressed genes was the H3K4me3/AcH3 modification
present in 33-38% of expressed gene promoters. The
double H3K4 and H3K27 trimethylation, marking so-
called bivalent poised genes was present in 4-5% of
genes; however, a mark for silenced genes, H3K27me3
alone, was clearly decreased (9-12%) among expressed
genes. Interestingly, we noted that during the differen-
tiation from monocytes to DCs, the proportion of genes
with H3K4me3 alone decreased from 14% to 5%, in con-
trast to the AcH3 mark, which increased from 2% to 6%
(Figure 3A). These changes, albeit to a lesser extent,
also occurred in macrophage differentiation (H3K4me3
decreased to 9% and AcH3 increased to 3%). Modifica-
tions on transcriptionally inactive genes were clearly dif-
ferent; the main modification on these gene promoters
was H3K27me3 alone (30-33%) or in combination with
H3K4me3 (7-11%). Only 7% to 8% of genes had the
double H3K4me3 and AcH3 mark (Figure 3B).
We next analyzed ChIP-chip data in relation to gene
expression levels to see the correlation of modifications
with gene activity. Analysis of the 2000 most highly
expressed genes in monocytes revealed that a vast
majority of genes have either the H3K4me3 or the
AcH3 modification, 89% and 67% respectively, on their
promoter whereas only 10% have the H3K27me3 mark
(Table 3). A highly significant correlation of H3K4me3
and AcH3 marks with a high expression level was also
seen in macrophage and DC populations. Though when
compared to monocytes, the proportion of genes in DCs
with the H3K4me3 modification was lower (82%) but
higher with the AcH3 mark (72%). The positive correla-
tion between an increased expression level and
H3K4me3 and AcH3 marks was even stronger among
the top 200 most highly expressed genes (data not
shown). In contrast, among the 2000 lowly expressed
genes, we saw a correlation with the H3K27me3 modifi-
cation in all three cell populations (monocytes, 56%;
macrophages, 47%; DCs, 54%), while the number of
genes having both the H3K4me3 and the AcH3 marks
was clearly smaller than in the 2000 highly expressed
genes (Table 3). It should be noted that the number of
genes without any of the three marks was rather similar
in both subsets of expressed genes.
Histone marks H3K4me3 and AcH3 alone are unstable
Histone modifications are highly dynamic. We therefore
analyzed the dynamics of histone modifications during
differentiation from monocytes to macrophages or DCs.
Figure 2 Correlation between H3K4me3, AcH3 and H3K27me3 modifications on gene promoters within monocyte, macrophage and
DC populations. Pearson correlation analysis of the studied modifications is shown in a color scale from red (high correlation rate) to blue (low
correlation). The corresponding correlation coefficients are shown in table. MO, monocytes; macrophages, MF; dendritic cells, DC.
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alone or in combination with each other during differ-
entiation, we found that the most prevalent mark char-
acteristic for active genes, the double H3K4me3/AcH3,
often persisted on genes throughout the differentiation
process (Figure 4). However, we noted a striking
decrease of H3K4me3 or AcH3 modifications when
occurring alone. For example, when present alone in
monocytes, the H3K4me3 mark was usually lost or
turned into double mark by an additional acetylation of
72% or 86% of corresponding genes in macrophages or
DCs, respectively. Similarly, 84-85% of genes with the
Figure 3 Frequencies of H3K4me3, AcH3 and H3K27me3 marks and their combinations among (A) transcriptionally active and (B)
inactive gene promoters. Frequencies of modifications are shown as percentages in scaled circles positioned to outer corners of the triangles.
Frequencies of co-occuring modifications are shown in between. Studied cell types are indicated left. “No mark” represents the lack of histone
modifications analyzed in this study.
Table 3 Frequency of H3K4me3, AcH3 and H3K27me3
modifications on 2000 genes with high or low expression
and their correlation P-values
Modification MO MF DC
High Low High Low High Low
H3K4me3 88.5* 49.2 81.1 46.5 81.7 41.5
2
e-167 6
e-118 2
e-65
AcH3 67.3 31.6 71.6 29.7 72.4 29.7
2
e-114 3
e-159 4
e-165
H3K27me3 9.9 56.4 7.7 47.1 10.1 53.8
4
e-230 2
e-185 6
e-207
*Frequency of marks is shown as % of the genes either with high or low
expression.
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Page 5 of 13AcH3 mark alone in monocytes lost this modification
status during differentiation to macrophages or DCs. In
contrast, the H3K27me3 modification alone was rela-
tively stable but less so when occurring in combination
with H3K4me3 (Figure 4). Together, these results
demonstrate a dynamic nature of histone modifications
during differentiation, and that the H3K4me3 and AcH3
modifications alone lead to either a loss of one of these
marks or a gain of the H3K4me3/AcH3 combinatorial
mark.
Modifications on marker genes often correlate with
transcriptional activity
To study the chromatin changes of genes associated
with macrophage and DC differentiation, we analyzed
the histone modifications on the promoters of several
well-established marker genes (Figure 5A). For example,
CD14 and CD4 genes had double H3K4me3/AcH3
mark on their promoters in monocytes, where they are
expressed at high levels, but in agreement with their
transcriptional downregulation, they lost these marks
after differentiation. CD8A and CD8B genes were not
expressed in any of these cells and were marked by
repressive H3K27me3 modification. The gene encoding
costimulatory ligand CD86 is relatively highly expressed
in all three cell types and has double H3K4me3/AcH3
mark but functionally related CD80 gene, which is
expressed at lower level, was marked by AcH3 only.
Also, the highly expressed integrin marker ITGAM/
CD11b had the H3K4me3 modification in monocytes as
well as macrophages and acquired the additional AcH3
mark in DCs. The expression of ITGAL/CD11a
decreased during differentiation with a corresponding
loss of H3K4me3 and AcH3 marks in DCs. Active
H3K4me3/AcH3 chromatin marks were also present on
integrin ITGAX/CD11c and SIRPA genes. In contrast,
the expression of CD40 and CD83 genes did not corre-
late with histone modifications (data not shown).
Genes related to phagocytosis and antigen presentation
have active chromatin marks
Phagocytosis and antigen presentation are the two most
central functions of monocytes and monocyte-derived
cells. We therefore studied the histone modifications of
genes involved in these two key categories of antigen pre-
senting cells in correlation with their expression levels. Out
of 15 genes associated with phagocytic function, the double
H3K4me3/AcH3 mark was present on 11 promoters in
monocytes, on 8 promoters in macrophage and on 6 pro-
moters in DC populations (Figure 5B, C). Also, a majority
of the 37 genes associated with antigen presentation,
including HLA (HLA-A, HLA-B, HLA-C, HLA-DRA
and HLA-DRB5, HLA-DPA1, HLA-DPB1, HLA-
DMA and HLA-DMB), beta-2-microglobulin (B2M),
Figure 4 Dynamics of histone modification and their
combinations. Gene sets with indicated histone modifications or
the combination of modifications present in monocytes (MO) were
analyzed further in macrophages (MFs) and DCs. The scale indicates
the number of genes in each set in monocyte population.
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Page 6 of 13proteasome-associated (PSMB5, PSMB8, PSMB9, PSMB10,
PSMF1, PSME2, and PSME3) and peptide transporter
(TAP1 and TAP2) had the double H3K4me3/AcH3 mark
on their promoters (23, 28 and 27 genes in monocytes,
macrophages and DC, respectively) (Figure 5B, C). These
data are in good agreement with the general functionality of
antigen-presenting cells, where monocytes and macro-
phages are more active in phagocytic activities while macro-
phages and DCs are more efficient in antigen presentation.
A majority of active transcription factor promoters have
the H3K4me3 mark
We next studied histone modifications on genes asso-
ciated with transcriptional processes. A majority of the
expressed transcription factor genes had the H3K4me3
modification on their promoter, often together with the
AcH3 mark, and a few with the H3K27me3 (Additional
file 1, Figure S4). More specifically, the upregulated
transcription factors BHLHE41/BHLHB3 (basic
Figure 5 Comparison of gene expression levels and H3K4me3, AcH3 and H3K27me3 modifications among functional gene groups in
monocytes, macrophages and DCs. Histone modifications and their correlation with expression levels among (A) individual genes of cell
markers and (B) genes involved in antigen presentation and phagocytosis. (C) Functional gene groups of antigen presention and phagocytosis
according to their expression levels and histone modification status in three cell populations. Color scale indicates expression level from no
expression (blue) to high expression (red). Dark green represents the presence and light green the absence of the modification.
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Page 7 of 13helix-loop-helix family, member e41), EGR2 (early
growth response factor 2), EPAS1/HIF2A (hypoxia-indu-
cible factor 2 alpha), and MSC (musculin, activated B
cell factor 1) had the bivalent H3K4me3/H3K27me3
mark in monocytes; however, the H3K27me3 mark was
lost in macrophages and DCs. Other upregulated tran-
scriptional factors such as PIR (pirin, iron-binding
nuclear protein), ESR1 (estrogen receptor), HES6 (hairy
and enhancer of split 6) and IRF4 (interferon responsive
factor 4) and KLF5 (Kruppel like factor 5) maintained
the H3K27me3 mark even after their upregulation dur-
ing differentiation. Interestingly, the ETS family member
EHF/ESE-3 did not have any modification. Notably,
many transcription factor families involved in differen-
tiation or lineage-specific regulation in other cell types
or tissues were marked with the silencing H3K27me3
mark (Additional file 1, Figure S5). For example, 38/39
HOX, 20/30 FOX, 11/195 SOX, 9/9 PAX, 8/8 LHX, 5/6
SIX, 8/11 POU, 6/6 NKX, 5/6 IRX, 6/6 NEURO and 5/6
GATA family transcription factors were positive for the
H3K27me3 modification in all three cell populations.
This also correlated with the overall transcriptionally
inactive status in all three cell types.
Next we used the program Opossum to compare the
occurrence of transcription factor binding motifs in
gene promoters with and without histone modifications.
We found a remarkable enrichment of ETS and C2H2
zinc finger family transcription factor sites in gene pro-
moters enriched with AcH3 modifications. The genes
with H3K4me3 marks were enriched for homeobox and
high mobility group (HMG) box transcription factor
binding sites. It is likely that the presence of these tran-
scription factors binding sites reflects their activity in
recruitment of histone modifier proteins to the promo-
ters [21,22].
The H3K4me3 modification correlates with the expression
in gene clusters
We noticed that while many genes had lower peak
scores, they still gained or lost their histone modifica-
tions during differentiation. This was particularly evident
with many cell surface marker and chemokine genes. To
identify these changes on all promoters, we subtracted
the monocyte-specific peak scores from those identified
in macrophages or DCs. This additional normalization
identified further changes that were not apparent by
standard peak identification. The profiling by Gene
Ontology indicated that the gain of H3K4me3 mark
often occurs on genes associated with signal transduc-
tion, inflammation and chemokine activity both in
macrophages and DCs after the differentiation whereas
the AcH3 was more associated with cell cycle, general
mRNA processing and gene expression regulation
(Additional file 2, Table S2). We then studied changes
among specific gene groups that were up- or downregu-
lated during differentiation. The H3K4me3 and AcH3
modifications were clearly decreased among monocyte
marker genes, such as CD14, CCR2, CX3CR1 and SELL.
In both macrophage and DC subsets, we found a promi-
nent increase in H3K4 methylation among their marker
genes TM7SF4/DC-STAMP, TREM2 and CD209/DC-
SIGN (Figure 6A). In addition to these individual genes,
we identified several gene families that showed either a
gain or loss of the H3K4me3 mark. Many of these gene
families were located in genomic clusters. For example,
we noticed that a gene clusters encoding upregulated
chemokines CCL2, CCL3, CCL13 and CCL23 on chro-
mosome 17q11.2 and CCL17, CX3CL1 and CCL22 on
chromosome 16q13 predominantly showed the
increased H3K4me3 levels in macrophages and DCs
(Figure 6B, C). Furthermore, the H3K4 methylation
levels were modified in several other gene clusters asso-
ciated with inflammatory and cell-cell interaction func-
tions. We found increased H3K4 methylation in the
clusters for: 5 family members of the CD1 transmem-
brane proteins that are structurally related to HLA, 3
complement subunit C1Q genes and 9 genes belonging
to the SLAM family receptors that modulate T-cell
responses as costimulatory signaling proteins (Figure
6D; Additional file 1 Figure S6). Genes from these clus-
ters were all upregulated in macrophages and DCs. In
contrast, the genes from clusters of the CD300 inhibi-
tory receptor family and the IFITM genes encoding
interferon-inducible membrane proteins were downre-
gulated and showed reduced H3K4me3 levels in macro-
phages and DCs (Additional file 1, Figure S6).
Interestingly, in many of these clusters we found that
the H3K4me3 changes were similar in macrophages and
DCs in spite of their differences in expression levels.
This suggests that chromatin changes are needed to
induce a permissive chromatin state on gene promoters
during differentiation, and that the mRNA expression
levels of each individual gene is further regulated by
other factors.
To confirm the ChIP-chip data, we studied the
H3K4me3 modification on several marker gene promo-
ters by conventional ChIP assay. As expected, the CD14
gene showed reduced whereas the TM7SF4/DC-
STAMP, TREM2, CD209/DC-SIGN and CD1A gene
promoters demonstrated increased levels of H3K4me3
(Additional file 1, Figure S7). Similarly, the chemokine
genes CCL13, CCL23, CCL17 and CCL22 showed
strongly elevated levels of the H3K4me3 marks. This
increase in H3K4me3 on chemokine genes was also pre-
sent in macrophages, albeit at lower level. Taken
together, our results demonstrate that several marker
genes and clustered gene families, including cell surface
receptors and CC chemokines that are activated during
Tserel et al. BMC Genomics 2010, 11:642
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Page 8 of 13differentiation into macrophages and DCs, show the
increase in H3K4 methylation on their promoters.
Discussion
The recent advent of new technologies analyzing gen-
ome-wide chromatin changes has greatly improved our
understanding of gene regulation and control. These
global approaches provide a large-scale picture to the
extent of changes and can be used for further dissection
of gene-specific modifications. Our genome-wide mRNA
expression profile and map of three major histone modi-
fications associated with gene expression in monocytes,
macrophages and DCs are an addition to previous stu-
dies in immune cells [23-27].
We found a high concordance rate between two active
promoter marks, H3K4me3 and AcH3, in all three
populations. Furthermore, the overall density of
H3K4me3 and AcH3 marks on promoter regions dis-
played a similar pattern, with two elevated peaks sur-
rounding transcription start site and a significant
Figure 6 Changes of H3K4me3 modification on selected gene promoters in DCs and macrophages compared to monocytes. Changes
are shown as log2 differences in peak intensities either in DCs or macrophages (MF) compared to monocytes and are presented either as gain
(positive values) or loss (negative values) of the modification. The filled gray shapes represent the positions of transcripts. The red and green
colors in boxes indicate up- and downregulation compared to the mRNA levels in monocytes. H3K4me3 modification changes of (A) cellular
marker genes of monocytes, DCs and macrophages, (B, C) chemokine gene clusters on chromosome chr17:29,606,409-31,457,127 and
chr16:55,950,219-56,007,475, respectively, and (D) CD1 cluster on chromosome chr1:156,490,551-156,593,967.
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Page 9 of 13decline at the point of transcription, representing
reduced levels of H3K4me3 and AcH3 in a region cov-
ered by RNA polymerase II and other regulatory pro-
teins [28,29]. As the respective peaks of H3K4me3 and
AcH3 marks by and large coincide, it is likely that they
also often co-occur in the same nucleosomes. Thus, our
data confirm a tight association of H3K4me3 and AcH3
modifications with permissive chromatin for transcrip-
tion in antigen-presenting cells. In contrast, H3K27me3
had an overall very low concordance with active marks
and was equally distributed over the promoter regions
with only slight decline at transcription start site.
The H3K4me3 mark was clearly a predominant modifi-
cation on gene promoters, and most commonly was
coupled with AcH3. This is in agreement with the earlier
reported genome-wide studies from embryonic stem cells
[30,31], CD4+ and CD8+ T cells [24-26], all reporting
H3K4me3 as the most characteristic modification in pro-
moter regions. The H3K4me3 mark was also strongly
correlated with the transcriptional activity of a gene.
Interestingly, we noticed a gradual decrease of the
H3K4me3 mark among active genes during the differen-
tiation of monocytes to DCs, and accordingly, the num-
ber of genes without any modification increased. It
should be noted that the global number of genes with a
detectable expression signal between the three cell popu-
lations did not change significantly. This suggests that
during differentiation, a subset of genes lose their
H3K4me3 mark independently of their gene expression
and also hints at a highly dynamic nature of histone
modifications during differentiation. When studying the
dynamics of histone modifications, we found that both
the H3K4me3 and AcH3 marks are unstable when they
occur alone and are prone to either lose the modification
(i.e. become a promoter without mark) or to gain another
permissive mark. In contrast, having the combination of
both the H3K4me3 and AcH3 marks in a gene promoter
was highly stable, and the majority of genes having this
combination of histone marks in monocytes also had it
in macrophages and DC. The overall decrease of the
H3K4me3 mark and the reciprocal increase of genes with
or without the H3K27me3 mark in the DC population
suggests that the ex vivo differentiation in the presence of
IL-4 induces a global shift towards less active chromatin.
At the single gene level we found many differences in
histone modification profiles, in particular between
monocytes and in vitro cultivated cells, which correlate
with their transcriptional changes. As expected, the
expression levels of many marker genes showed a good
correlation with the presence of active histone modifica-
tions. When we analyzed the gain or loss of marks dur-
ing differentiation, we found a remarkable decline in the
H3K4me3 mark on several monocyte-specific marker
genes and a corresponding increase in promoters of
DC-specific genes. The prominent exceptions were the
CD83 and CD40 genes, which were not associated with
any histone mark. Similar to marker genes, the genes
associated with antigen presentation activity and phago-
cytosis were expressed at high levels and had either the
H3K4me3 or AcH3 mark. Notably, genes that are asso-
ciated with phagocytosis had more permissive
H3K4me3/AcH3 mark in their promoters in the mono-
cyte population, whereas the genes associated with anti-
gen presentation had more H3K4me3/AcH3 mark in
macrophages and DCs. Although there was no dramatic
difference between the cell populations in general, this
correlation of histone modifications argues in favor of
the role of histone modifications in these two key func-
tions of antigen-presenting cells. In case of transcription
factors, the situation was more complex, and in many
cases the pattern of transcriptional activity of the gene
did not match with expected histone modifications.
However, the silencing H3K27me3 modification marked
a vast majority of transcription factors involved in devel-
opment or lineage decision in other cell types.
In our analysis, we identified several genomic clusters
with changes in their chromatin status suggesting that
histone modifications in genomic loci are coordinately
regulated. In particular, we found that in macrophages
and DCs, H3K4me3 levels increased in a large genomic
cluster of proinflammatory and chemotactic CC chemo-
kines on chromosomes 17q11.2 and 16q13 [32]. Typi-
cally, CC chemokines attract mononuclear cells and/or
are induced in an inflammatory environment, thus our
findings suggest the requirement of histone modifica-
tions on chemokine gene clusters for their responses to
inflammatory situations. These changes in H3K4me3
modifications were not limited to chemokine gene clus-
ters as we found similar changes in other gene clusters
involved in inflammatory processes (CD1, C1Q, SLAM,
CD300 and IFITM families). Interestingly, we noted that
even when the gene expression levels in macrophages
and DCs differed, the histone marks in these two cell
populations were often similar. This indicates that the
histone modification status might be established before
the actual expression of the gene and serve as a prere-
quisite for rapid activation by gene-specific transcription
factors upon inflammatory stimuli. However, changes in
chromatin modifications may also occur during subse-
quent activation steps. For example, studies in murine
bone marrow derived macrophages showed that genes
induced by TLR4 stimulation can be divided into two
subclasses based on their gene-specific activation and
histone H4 acetylation [33]. Our work here provides a
basis for the further studies to address the role of his-
tone modifications in chemokine and other gene clusters
in human macrophages and DCs after the activation
with inflammatory stimuli.
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The results of genome-wide promoter analysis of
H3K4me3, H3K27me3 and AcH3 histone modifications
in monocyte-derived macrophage and DCs show specific
correlation between the expression of functional gene
groups, including marker and chemokine genes, and
their chromatin state on promoters. Our data describe
several differences of H3K4me3 modification profiles in
monocytes, macrophages and DCs but also suggest that
the chromatin status of functionally important gene
clusters is coordinately modified. Together, the results
provide a functional correlation between gene expres-
sion and histone modifications in monocyte-derived
macrophages and DCs.
Methods
Cell culture
Monocytes were purified from freshly collected buffy
coats obtained from blood donors of Tartu University
Hospital’s Blood Center. The study was approved by the
Ethics Review Committee on Human Research of the
University of Tartu, Estonia (protocol numbers 170/T-7
and 182/M-1). All participants were older than 18-years
and gave written informed consent. PBMC were
prepared by density gradient centrifugation on
Ficoll-Paque™PLUS (GE Healthcare Bio-Sciences AB).
Monocytes were purified by positive sorting using anti-
CD14-conjugated magnetic microbeads and by two runs
through LS columns (both from Miltenyi Biotech) to
obtain purities over 99%. The cells were differentiated
into macrophages using 50 ng/ml GM-CSF and into
DCs using 50 ng/ml GM-CSF and 25 ng/ml IL-4 (both
from PeproTech) for 6 d at 1 million cells/ml in RPMI
1640 supplemented with 2 mM L-glutamine, 100 U/ml
penicillin, 100 μg/ml streptomycin and 10% FCS (all
from PAA). The expression of surface proteins on
monocytes, macrophages and DCs were analyzed using
fluorescence conjugated antibodies CD14, DC-SIGN,
CD80 and CD83 (Miltenyi) and FACSCalibur (BD Bios-
ciences) to confirm the characteristic phenotype (Addi-
tional file 1, Figure S8).
Illumina gene expression array
RNA was extracted using the Trizol reagent (Invitrogen)
and RNeasy Mini Kit (Qiagen). The concentration of
RNA was assessed with NanoDrop ND-1000 spectro-
photometer (NanoDrop Technologies) and the quality
with Agilent RNA 6000 Nano Kit and Agilent 2100
Bioanalyzer (Agilent Technologies). RNA integrity num-
bers (RIN) indicated good quality of RNA, ranging from
6.5 to 9.3. Illumina TotalPrep RNA amplification Kit
(Ambion Inc.) was used to amplify 330 ng RNA for
hybridization on Illumina Human-6 v2 BeadChips (Illu-
mina). The data were analyzed with BeadStudio Gene
Expression Module v3.3.7 (Illumina) using Illumina’s
custom rank invariant method. The complete lists of
upregulated and downregulated genes are available at
ArrayExpress databank with accession number
E-TABM-976 (see also Additional file 2, Tables S3, S4).
Chromatin immunoprecipitation (ChIP)
ChIP with some modifications was performed according
to Upstate Chromatin Immunoprecipitation Assay pro-
tocol (Upstate). Briefly, formaldehyde crosslinking was
carried out in PBS containing 1% formaldehyde and 0.5
mM EGTA with the density of 7x10
7 cells in 70 ml. To
process monocyte samples in parallel with macrophages
and DCs, monocyte samples were crosslinked, lysed and
subjected to sonication in day one and the lysates were
kept at 4°C until macrophage and DC samples were col-
lected. About 1x10
7 cells, 30 μlo fp a c k e dp r o t e i nG
sepharose beads (GE Healthcare; pre-absorbed with 100
μg/ml BSA and 500 μg/ml of sheared salmon sperm
DNA) and 4 μg of H3 (Abcam, ab1791), H3K4me3
(Abcam, ab8580), H3K27me3 (Upstate, 07-449) or
AcH3 (Upstate, 06-599) antibodies were used in each
immunoprecipitation. DNA probes from ChIP were
amplified using GenomePlex Complete Whole Genome
Amplification (WGA) Kit and reamplified using
GenomePlex WGA Reamplification Kit (both from
Sigma-Aldrich). NimbleGen Systems using 385K RefSeq
Promoters array set performed sample labelling, hybridi-
zation and data extraction. The NimbleGen RefSeq Pro-
moter array data is available at ArrayExpress databank
with accession number E-TABM-979 (see also Addi-
tional file 2, Tables S5, S6).
For conventional ChIP, purified DNA samples were
analyzed in triplicate by quantitative PCR (qPCR) as
described in [34]. In addition, datasets of each primer
p a i r sw e r en o r m a l i z e dt om o n o c y t eH 3v a l u e s .T h ep r i -
mers were designed with MPrimer3 http://bioinfo.ut.
ee/mprimer3/[35] and are shown in Additional file 2,
Table S1.
Bioinformatic analyses
The intensities of the histone H3, H3K4me3, H3K27me3
and AcH3 probes were first normalized to the random
genomic background. We additionally normalized the
modification intensities by subtracting H3 intensities
from the corresponding modification intensities to get
specific values for each modification. The normalized
values correspond to log2 ratio between corresponding
modification and H3 signals. We used the same normal-
ization to find the changes induced by differentiation
but then we subtracted the values of probe intensities in
monocyte from corresponding probe intensities in
macrophage and DCs. Both sets of data were further
used to find peaks in the promoters. The peaks were
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2000 bp upstream to 500 bp downstream from the tran-
scription start site. The peak scan and assembly with
normal RefSeq genes for human genome (HG18, NCBI
Build 36) was performed using Nimblescan 2.5 software
with default settings. The number of transcript probes
in Illumina gene expression matrix was 42620 and the
Nimblegen promoter database contained 19222 genes.
In the analyses combining gene expression and promo-
ter modification data, the overlap between these two
sets (17289 genes) was used. The genes for functional
classes were selected from Immunome Database http://
bioinf.uta.fi/Immunome/[36] and the list of transcription
factors was accumulated using Ingenuity Pathway Analy-
sis software http://www.ingenuity.com/[37].
The transcription factor analysis was performed using
web resource Opossum [38], which identifies transcrip-
tion factor binding motifs that are overrepresented in
input genes compared to background of all genes. We
used only vertebrate motifs that are most conserved
from the top 10% of the most conserved regions (mini-
mum conservation 70%). The matrix match threshold
was 80% of the maximal match score. The significance
threshold was combined from Z-score, calculated
assuming binomial distribution of total number of motif
occurrences, and Fisher one-tail test p-value, comparing
number of promoters having the motif. The correspond-
ing thresholds were 10 for Z-score and 0.01 for Fisher
test p-value. The promoters used in this case were from
2000 bp upstream to transcription start site, as this
choice was in the best agreement with the tiling chip
promoter areas.
The functional profiling for the groups of genes with
changes in the studied modifications was carried out
using the g:GOSt tool at g:Profiler website http://biit.cs.
ut.ee/gprofiler/[39] that retrieves most significant Gene
Ontology (GO) terms, KEGG and REACTOME path-
ways [40].
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